Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Monday, November 23, 2009, 7:19AM AEST - The Australian Stockmarket opens in 2 hours and 41 minutes.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
CSL Limited (CSL.AX)
On Nov 20:
31.530 AUD
0.000 (0.00%)
MORE ON CSL.AX
Quotes
Summary
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Announcements
Company Events
Message Board
Company
Profile
Key Statistics
Ownership
Insider Trans.
Institutional Trans.
Financials
Earnings Summary
Balance Sheet
Cash Flow
CSL FPO
(ASX:CSL.AX) Delayed quote data
Last Trade:
31.530 AUD
Trade Time:
Nov 20
Change:
0.000 (0.00%)
Prev Close:
31.530
Open:
31.600
Bid:
N/A
Ask:
N/A
1y Target Est:
N/A
Day's Range:
31.400 - 31.690
52wk Range:
26.850 - 38.520
Volume:
1,408,354
Avg Vol
(3m)
:
2,881,170
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add CSL.AX to Portfolio
Download Data
HEADLINES
Swine flu may have hit one peak; more to come
at Reuters
(Sat, Nov 21)
UPDATE - Swine flu may be peaking in US, reports indicate
at Reuters
(Sat, Nov 21)
Did U.S make mistake in skipping vaccine additive?
at Reuters
(Sat, Nov 21)
Regulation, suspicion slow US flu response -hearing
at Reuters
(Thu, Nov 19)
UPDATE - US officials defend swine flu vaccination plan
at Reuters
(Wed, Nov 18)
US HHS has not learned from H1N1 mistakes-senators
at Reuters
(Tue, Nov 17)
UPDATE - H1N1 has killed 3,900 Americans, U.S. CDC says
at Reuters
(Fri, Nov 13)
CSL Biotherapies Obtains FDA Licensure for Use of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine in Children
Business Wire
(Thu, Nov 12)
CSL Biotherapies Obtains FDA Licensure for Use of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine in Children
Business Wire
(Thu, Nov 12)
Flow of H1N1 vaccines picking up in U.S., CDC says
at Reuters
(Wed, Nov 11)
More Headlines for CSL.AX...
BUSINESS SUMMARY
CSL Limited (CSL)'s activities comprise the development, manufacture, marketing and distribution of pharmaceutical and allied products. The bulk of its sales are derived from pharmaceutical and bioplasma divisions.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices